Bacteria and inflammation thrives in the presence of heme, iron. Diabetes starts with inflammation. A1c in the blood shows the 3-month average plasma glucose concentration. CVD, cardiovascular disease, is an inflammation of the vascular system.

Deaths from CVD: 17.9 million / 32% (2015)

Researchers analyzed 14 exercise studies involving 915 adults with type 2 diabetes. Aerobic exercise (such as walking and bike riding) was better at lowering A1C levels—a measure of blood glucose control for the past two to three months—than was resistance training (such as lifting weights).

Email for the Homocysteine with CBC Chemistry Profile blood test from Life Extension for $119. Use paypal account . Free health coaching is included.

From wiki:

Glycated hemoglobin (hemoglobin A1cHbA1cA1C, or Hb1c; sometimes also referred to as being Hb1c or HGBA1C) is a form of hemoglobin that is measured primarily to identify the three-month average plasma glucose concentration. The test is limited to a three-month average because the lifespan of a red blood cell is four months (120 days). However, since RBCs do not all undergo lysis at the same time, HbA1C is taken as a limited measure of 3 months. It is formed in a non-enzymatic glycation pathway by hemoglobin’s exposure to plasma glucose. HbA1c is a measure of the beta-N-1-deoxy fructosyl component of hemoglobin.[1]

The origin of the naming derives from Hemoglobin type A being separated on cation exchange chromatography. The first fraction to separate, probably considered to be pure Hemoglobin A, was designated HbA0 , the following fractions were designated HbA1a, HbA1b, and HbA1c, respective of their order of elution. There have subsequently been many more sub fractions as separation techniques have improved.[2] Normal levels of glucose produce a normal amount of glycated hemoglobin. As the average amount of plasma glucose increases, the fraction of glycated hemoglobin increases in a predictable way. This serves as a marker for average blood glucose levels over the previous three months before the measurement as this is the lifespan of red blood cells.

In diabetes mellitus, higher amounts of glycated hemoglobin, indicating poorer control of blood glucose levels, have been associated with cardiovascular diseasenephropathyneuropathy, and retinopathy. A trial on a group of patients with Type 1 diabetes found that monitoring by caregivers of HbA1c led to changes in diabetes treatment and improvement of metabolic control compared to monitoring only of blood or urine glucose.[3] However, a trial designed specifically to determine whether reducing HbA1c below the normal 6%, using primarily insulin and sulfonylureas (both known to easily drive blood sugar too low), would reduce the rate of cardiovascular events in Type 2 Diabetes found higher mortality—the trial was terminated early.[4] The negative outcomes may well have been a result of the treatment approach, primarily insulin and sulfonylureas, utilized in the “intensive” treatment group instead of LCHFGlP-1 analogues & SGLT-2 inhibitors, none of which have these problems & lower cardiovascular mortality.

A1c p0A1c p1

Bacterial Heme Toxicity and DNA damaging process

Virtually all bacterial pathogens require iron to infect vertebrates. The most abundant source of iron within vertebrates is in the form of heme as a cofactor of hemoproteins. Many bacterial pathogens have elegant systems dedicated to the acquisition of heme from host hemoproteins. Once internalized, heme is either degraded to release free iron or used intact as a cofactor in catalases, cytochromes, and other bacterial hemoproteins. Paradoxically, the high redox potential of heme makes it a liability, as heme is toxic at high concentrations. Although a variety of mechanisms have been proposed to explain heme toxicity, the mechanisms by which heme kills bacteria are not well understood. Nonetheless, bacteria employ various strategies to protect against and eliminate heme toxicity. Factors involved in heme acquisition and detoxification have been found to contribute to virulence, underscoring the physiological relevance of heme stress during pathogenesis. Herein we describe the current understanding of the mechanisms of heme toxicity and how bacterial pathogens overcome the heme paradox during infection.

Iron is an essential cofactor for many enzymes found within all kingdoms of life.

Bacterial pathogens are no exception to this rule, and therefore, they must acquire iron from their hosts in order to cause disease. Iron is a transition metal that can cycle between redox states, making it a valuable cofactor for biological processes. Ferric iron is water insoluble, and as such, it requires specialized proteins to facilitate its mobilization and to maintain intracellular reservoirs. In mammalian species, lactoferrin and transferrin transport iron, while ferritin stores iron. The most abundant form of iron in vertebrates, however, is bound within a porphyrin ring as ferriprotoporphyrin IX (heme). Heme solubilizes iron and enhances its catalytic ability by 5 to 10 orders of magnitude (14111). This catalytic activity is harnessed by hemoproteins involved in oxygenation reactions, oxidative stress responses, electron transport, oxygen transport, oxygen sensing, and oxygen storage. While heme is a necessary prosthetic group for many proteins, it also has the potential to cause toxicity at high concentrations. This property of heme requires that the intracellular pool of heme be tightly regulated.

Intracellular heme concentrations within vertebrates are tightly controlled by balancing the rates of heme biosynthesis and catabolism (87). Free heme released into the plasma by the dissolution of hemoproteins from lysed erythrocytes is quickly scavenged by albumin, hemopexin, and the serum lipocalin α1-microglobulin (13234475). Any hemoglobin released into the serum is tightly bound by haptoglobin and subsequently cleared by tissue macrophages (51). It is evident that the vital yet reactive nature of heme requires that its production, degradation, and availability be carefully controlled in metazoans. Meeting these demands reduces heme-mediated toxicity and minimizes surplus free heme.

Most bacterial pathogens that infect vertebrate tissues have systems dedicated to the acquisition of heme for use as a nutrient iron source. However, the toxicity of heme presents a paradox for microorganisms that satisfy their nutrient iron requirement through heme acquisition. This heme paradox is resolved through tightly regulated systems dedicated to balancing the acquisition of heme with the prevention of heme-mediated toxicity.


Heme acquisition systems.

Bacterial pathogens can circumvent nearly every vertebrate form of heme sequestration. Bacterial heme acquisition systems that extract heme from hemopexin, heme-albumin, hemoglobin, and hemoglobin-haptoglobin have been identified in both Gram-negative and Gram-positive species (116) (Fig. (Fig.1).1). In Gram-negative bacteria there are three known classes of heme transport systems: direct heme uptake systems, bipartite heme receptors, and hemophore-mediated heme uptake systems (116).

FIG. 1.

Mechanisms of bacterial heme acquisition. Bacteria can utilize multiple heme sources found within the vertebrate host. Three types of heme acquisition systems have been identified for Gram-negative bacteria (left). These systems include direct heme uptake 

Direct heme uptake systems bind heme-containing proteins at the outer membrane (OM) of Gram-negative bacteria and transport heme into the periplasm in a TonB-dependent manner (116) (Fig. (Fig.1A).1A). TonB is part of a cytoplasmic membrane complex that couples the proton motive force of the inner membrane to the outer membrane for the energy-dependent uptake of specific substrates, such as heme, into the periplasm (50100104). Once in the periplasm, heme is bound by a heme transport protein (HTP) (116). The heme-HTP complex shuttles heme to an ABC transporter in the inner membrane, through which heme is transported into the cytoplasm in an ATP-dependent process (116). A cytoplasmic protein is typically encoded within direct heme uptake operons, although the exact function of this family of proteins remains unclear. A specific example of a direct heme-binding uptake system is Pseudomonas aeruginosa phuR-phuSTUVW, where PhuR is the outer membrane receptor, PhuT is the HTP, PhuUVW is the ABC transporter, and PhuS is the cytoplasmic protein (5379117). Other pathogens encoding similar direct heme uptake systems include Bordetella pertussisYersinia pestisYersinia enterocoliticaShigella dysenteriaeVibrio choleraeCampylobacter jejuniBartonella quintana, and Escherichia coli O157:H7 (69708495112115118121).

Bipartite heme receptors have been identified only for Neisseria spp. These heme acquisition systems consist of a TonB-dependent outer membrane receptor, HpuB, and an outer membrane lipoprotein, HpuA (60) (Fig. (Fig.1B).1B). The bipartite nature of HpuAB distinguishes it from the direct heme uptake systems, which have only a single-component TonB-dependent receptor (121). HpuA and HpuB form a functional complex, and both are required for the utilization of hemoglobin and hemoglobin-haptoglobin as nutrient iron sources (5961). Coincidentally, a spontaneous point mutation in Neisseria gonorrhoeae pilQ (pilQ1) suppresses the mutant hpuAB phenotype (16). PilQ forms a channel in the outer membrane and is required for pilus biogenesis, but its mutant form allows the entry of heme and various antimicrobial compounds with a TonB-independent, PilT-dependent mechanism (16). This suggests that PilQ or the pilus apparatus may regulate the free diffusion of heme into N. gonorrhoeae and highlights the concept that bacteria carefully regulate their intracellular pool of heme.

Hemophore-mediated heme uptake systems involve a secreted heme-binding protein called a hemophore (Fig. (Fig.1C).1C). Holo-hemophores are recognized by an outer membrane receptor that mediates the import of heme. Two types of hemophore-mediated heme uptake systems have been described for Gram-negative bacteria: one uses the HasA hemophore, and the other uses the HxuA hemophore (116). The HasA hemophore-mediated heme uptake system has been identified in Serratia marcescensP. aeruginosaPseudomonas fluorescens, and Y. pestis (445565896). The HasA system encodes an export complex (HasDEF), a hemophore receptor (HasR), and regulatory proteins (HasI and HasS) (7153397116). Either TonB or the TonB homolog HasB provides the energy necessary for transporting heme from the surface-exposed HasR-HasA-heme complex into the periplasm (83). HasR can also bind free heme and hemoglobin-bound heme, but these processes are less efficient than HasA-mediated heme acquisition (3357). The HxuA system has been described only for Haemophilus influenzae type b (Hib) and consists of the hxuCBA gene cluster (19). HxuB is thought to export HxuA into the environment where HxuA binds the heme-hemopexin complex (19). The receptor for the heme-HxuA complex has not yet been determined, although HxuC is a likely candidate (19). While the HxuA system increases the diversity of utilizable heme substrates, the HasA system increases the efficiency of heme uptake (20).

Less diversity has been discovered for the heme uptake systems of Gram-positive bacteria. In general, Gram-positive heme uptake systems consist of surface-exposed receptors that shuttle heme through the cell wall to an ABC transporter for delivery into the cytoplasm (123) (Fig. (Fig.1D).1D). The paradigm for Gram-positive heme uptake is represented by the Staphylococcus aureus iron-regulated surface determinant system (Isd). The Isd import machinery is encoded by 10 genes, including four cell wall-anchored proteins (IsdABCH), a transpeptidase (SrtB), a membrane transport system (IsdDEF), and two cytoplasmic heme oxygenases (IsdG and IsdI) (94). IsdB and IsdH are responsible for binding hemoglobin and hemoglobin-haptoglobin, respectively (24). IsdA extracts heme from IsdB or IsdH for passage to IsdC (647394131). This efficient heme-scavenging system brings heme across the membrane into the cytoplasm through the IsdDEF ABC transporter, where it can either be degraded by the heme oxygenases IsdG and IsdI to release free iron or be trafficked intact to the cell membrane (6894). The function of exogenously acquired nondegraded heme in S. aureus remains to be elucidated. The Isd locus is present in numerous other Gram-positive pathogens, including Listeria monocytogenesBacillus anthracis, and Clostridium tetani (103116).

Other Gram-positive heme acquisition systems distinct from the Isd system have been identified for Corynebacterium spp. and Streptococcus spp. The Corynebacterium diphtheriae heme uptake system is encoded at a genomic locus containing htaC-htaA hmuTUV-htaB. HtaA and HtaB are membrane-associated and surface-exposed proteins thought to be heme receptors, while HmuUV is an ATP transporter that receives heme from HmuT and delivers it into the cytoplasm (3). The exact transport order of heme between HtaAB and HmuTUV has yet to be defined. In a manner similar to that of Corynebacterium diphtheriae Hta/Hmu, Streptococcus spp. encode surface-exposed heme-binding proteins (Shp and Shr) and an ABC transporter (HtaABC) (130). These systems are reminiscent of the Gram-negative direct heme transporters, except that the receptors and heme transport proteins are able to traffic heme through the thick cell wall of Gram-positive bacteria.

Only one hemophore-mediated heme uptake system has been described for Gram-positive bacteria (Fig. (Fig.1E).1E). B. anthracis encodes an Isd heme uptake system that is both similar to and distinct from that of S. aureus(3267). Two proteins unique to B. anthracis are the secreted hemophores IsdX1 and IsdX2 (2667). IsdX1 is capable of removing heme from hemoglobin and passing heme to IsdC or IsdX2 (26). From IsdC, heme is transported into the cytoplasm through the Isd system. IsdX2 is both extracellular and associated with the cell surface, but the exact physiological role that IsdX2 serves in heme acquisition has yet to be defined (26).

Heme biosynthesis.

Most Gram-positive and Gram-negative pathogens have developed mechanisms for acquiring heme from their hosts, yet many of these organisms are also capable of synthesizing heme endogenously. Bacteria such as Streptococcus spp., Mycoplasma spp., H. influenzaeEnterococcus faecalisLactococcus lactisBartonella henselaeBorrelia burgdorferi, and Treponema pallidum do not have the complete machinery to make their own heme, and as such, they either do not require heme-iron or rely on heme acquired from the environment (12828898). In comparison, the majority of bacteria with sequenced genomes contain the machinery for making heme, including bacteria from the AlphaproteobacteriaBetaproteobacteriaGammaproteobacteriaEpsilonproteobacteriaBacillalesLactobacillalesSpirochaetales, and cyanobacteria (3543116).

The physiological relevance of both synthesizing and acquiring heme has remained elusive. Since the final step of heme biosynthesis requires iron to be inserted into the protoporphyrin IX (PPIX) ring, it is likely that bacteria synthesize heme only in environments where iron is available, as has been observed for Bradyrhizobium japonicum (90). In turn, when bacteria capable of both heme biosynthesis and acquisition are in environments that are iron poor, they may switch to utilizing exogenous heme as an iron source. In some bacteria such a response is controlled by the ferric uptake regulator Fur. Under iron-replete conditions, Fur represses the expression of heme uptake machinery in many species, including S. aureusY. pestis, and P. aeruginosa (6879115116). An alternative way of understanding the duality of heme acquisition and biosynthesis may lie in the energetic repercussions of heme biosynthesis compared to those of acquisition. Simply put, it may be less energetically expensive to acquire heme rather than synthesize it. While understandings of bacterial heme biosynthesis and acquisition processes individually have grown significantly, much has yet to be discovered about the interplay between the regulation and physiological uses of endogenous and exogenous heme.

For those bacteria capable of heme biosynthesis, the process is fairly conserved. The first universal heme precursor is δ-aminolevulinic acid (ALA). ALA can be synthesized either from succinyl coenzyme A (CoA) and glycine by ALA synthase (hemA) (Fig. (Fig.2A)2A) or from glutamyl-tRNAGlu by the C5 pathway using GtrA and HemL (Fig. (Fig.2B).2B). Currently, no bacteria are known to use both routes to synthesize ALA, and hemA has been identified only in the Alphaproteobacteria (82). GtrA is the more ubiquitous enzyme used by bacteria to synthesize ALA. In some cases, the gtrA gene has been annotated as hemA, although this enzyme is not the same as ALA synthase and should be identified as gtrA to highlight its distinct function from that of HemA.

FIG. 2.

Schematic of heme biosynthesis in bacteria. The first universal heme precursor is δ-aminolevulinic acid (ALA). ALA can be synthesized by one of two routes, although no bacteria are known to use both ALA synthesis pathways. (A) Succinyl-CoA and 

Once ALA has been synthesized, a series of seven reactions convert eight molecules of ALA into protoheme. This protoheme can be used directly or modified further before being employed as a prosthetic group in hemoproteins. The heme biosynthesis pathway is fully diagrammed in Fig. Fig.2C.2C. Two specific steps in heme biosynthesis of particular note are those that convert coproporphyrinogen III to protoporphyrinogen IX and then transform protoporphyrinogen IX into protoporphyrin IX. Each of these steps can be performed by two enzymes that are functionally redundant, but the distinguishing feature between each pair of enzymes is that one is oxygen dependent and the other is oxygen independent (82). The oxygen-dependent enzymes are found in eukaryotes and are less prevalent in prokaryotes (82). This may allow bacteria to be metabolically flexible and use alternative electron donors to synthesize heme in the absence of oxygen.


Whether through heme biosynthesis or through heme acquisition systems, most bacteria dedicate significant efforts to ensuring an adequate supply of heme. However, the utility of heme is inseparable from its toxic effects, and the degree of sensitivity to heme toxicity varies among bacteria. In general, Gram-positive bacteria are more sensitive to heme toxicity than are Gram-negative bacteria (78). Notable exceptions to this trend are the anaerobic Gram-positive Clostridium spp. and Gram-negative Porphyromonas spp., of which about 40% and 94% of tested strains are sensitive to heme toxicity, respectively (78). The variation in heme sensitivity observed across bacteria suggests one of two possibilities. First, bacteria less sensitive to heme may have more-robust mechanisms of heme tolerance. Alternatively, distinct bacterial genera may produce differing levels of toxic by-products upon heme exposure. Despite bacterial heme sensitivity being recognized for over 60 years, the mechanisms by which heme kills bacteria remain undefined.

One possible mechanism of heme toxicity may be mediated by free iron released during heme degradation by bacterial heme oxygenases (77102). Free iron causes intracellular damage mediated through the production of hydroxyl radicals via Fenton chemistry or through lipid peroxidation (25). The question remains, however, whether heme oxygenases release enough iron to exceed available iron-binding sites within the cell and cause cellular toxicity. The lack of in vivo data demonstrating that iron-mediated lipid peroxidation and Fenton chemistry are the causes of cellular damage after heme exposure support the idea that iron released from heme may not be the cause of heme toxicity. In addition, noniron metalloporphyrins are toxic to S. aureus, although they are not degraded by the staphylococcal heme oxygenases IsdG and IsdI (55113). This suggests that free metals, including iron, are not likely to be the main cause of metalloporphyrin toxicity. In this regard, it is likely that the offending agent is the heme itself (25).

Due to the lack of data regarding mechanisms of heme toxicity in bacteria, models of bacterial toxicity may be extrapolated from eukaryotes. In erythrocytes, free heme disrupts the cell membrane, resulting in hemolysis by a colloid-osmotic mechanism: the cell no longer maintains ion gradients, potassium leaks out, and water enters due to the osmotic gradient (184999). Other eukaryotic cells do not undergo lysis in the presence of heme, although in vitro, endothelial cells are susceptible to heme toxicity by either the peroxidase-like or monooxygenase-like activities of heme (63). The monooxygenase-like reactivity of heme is the cause of heme-mediated DNA and protein damage in vitro and is most likely the mechanism of heme toxicity in metazoans (1263).

The outer layers of the bacterial cell are notably different from eukaryotic membranes in lipid composition, cell wall, and structure. These outer layers act as an armament that protects the bacterial cell from a multitude of environmental insults. Therefore, it is possible that these eukaryotic mechanisms of heme toxicity do not translate to bacteria, as no reports of heme-induced bacterial lysis have been identified. Gram-negative species such as Y. pestisAeromonas salmonicidaShigella flexneriPrevotella spp., and Porphyromonas spp. accumulate heme in their outer surface (21344262105). Rather than a source of toxicity, this accumulation of heme is thought to contribute to bacterial pathogenesis by increasing bacterial heme storage, utilization, or host invasion (21313441105). Moreover, iron-replete S. aureuspreferentially traffics exogenously acquired heme to the cell membrane, although the function of this process is still unknown (94). Of the species that accumulate heme in their membranes, S. aureus and Porphyromonas spp. are highly susceptible to heme toxicity, while Y. pestis and many Prevotella spp. are highly resistant to heme toxicity (485160). This brief survey suggests that the accumulation of heme on the bacterial surface does not correlate with toxicity. Bacterial heme toxicity appears to depend more on species-specific properties. One piece of evidence to support this notion is that Gram-positive and not Gram-negative bacteria accumulate DNA damage when exposed to heme in vivo (76).

The mechanism of heme-mediated toxicity is multifaceted. While much is known about eukaryotic heme toxicity, the relevance of these findings to bacteria remains unclear. The main cause of bacterial heme toxicity is not due to the release of free iron by cellular monooxygenases or by the peroxidase-like activity of heme (5563111). Some heme toxicity may be due to its monooxygenase-like reactivity, but this has not been directly tested for bacteria (76). Based on what has been reported, a likely cause of bacterial heme toxicity is its ability to damage DNA; however, the two have not been directly correlated (63). Taking these facts into consideration, it is likely that many mechanisms of heme toxicity have yet to be discovered.


While the mechanism of bacterial heme toxicity is not well defined, several means by which bacteria avoid heme toxicity have been characterized. The regulation of biosynthesis and the regulation of uptake are two ways by which bacteria control intracellular levels of heme. When the regulation of heme uptake and biosynthesis is not sufficient to prevent heme toxicity, other mechanisms that are utilized by bacteria include export, sequestration, and degradation. These are discussed in greater detail below and are summarized in Table Table11.


Mechanisms of heme tolerance


S. aureus, one of the pathogens most sensitive to heme, has a heme-regulated transporter (HrtAB) that alleviates toxicity (119). A mutation of the hrtAB transporter genes results in a further increase in heme sensitivity (106). The mechanism by which HrtAB alleviates heme toxicity has yet to be elucidated; however, HrtAB is thought to pump out either heme directly or a toxic metabolite of heme accumulation. Orthologous HrtAB systems have been characterized for Streptococcus agalactiaeB. anthracis, and L. lactis (2785107). Mutations in either the B. anthracis or L. lactis Hrt systems also result in increased sensitivity to heme toxicity (85107). The S. agalactiae hrtAB mutant has not been generated, so the contribution of HrtAB to resisting heme toxicity in this organism has yet to be determined. Other Gram-positive pathogens and saprotrophs that encode putative Hrt systems include L. monocytogenes and Listeria inocua of the listeriae, Bacillus thuringiensis and Bacillus cereus of the bacilli, and Staphylococcus epidermidis of the staphylococci (22108). Notably absent from this list are the nonpathogenic, nonsaprotrophic bacilli B. subtilis and B. licheniformis. This observation suggests that the Hrt system may have evolved in bacteria that come into contact with vertebrate blood to protect them from heme toxicity. This point is underscored by the upregulation of B. anthracis hrtAB in an animal model of anthrax (107).

A dual-operon efflux system has recently been identified for S. agalactiae, comprised of pefAB and pefRCD (27). PefAB and PefCD are two putative heme and protoporphyrin IX (PPIX) efflux pumps, although the role of PefB may be as an accessory protein rather than an actual pump (27). When the pefoperons are disrupted, the intracellular levels of heme and PPIX increase, causing enhanced sensitivity to heme toxicity (27). In addition to pefAB and pefRCDS. agalactiae also encodes orthologs of hrtAB, which are transcribed at higher levels than pefAB and pefCD at high heme concentrations (27). This suggests that the pef transporters are utilized to fine-tune intracellular heme levels, while hrtAB is employed to protect S. agalactiae from heme toxicity in heme-rich environments (27). The differential activity of two heme-regulated transport systems highlights the delicate balance that S. agalactiae maintains to cope with the heme paradox.

Other transporters with broader substrate specificity also provide some protection from heme toxicity. The multiple-transferable-resistance (Mtr) efflux system provides resistance to hydrophobic agents in N. gonorrhoeae (37). The inactivation of mtrCDE causes increased susceptibility to heme, while the overexpression of this efflux pump results in increased tolerance to heme toxicity (9). It is possible that the ability of general efflux systems to provide some resistance to heme is a conserved detoxification strategy used by many bacteria.


The best example of heme sequestration to avoid heme toxicity is in the eukaryotic parasite Plasmodium spp., the causative agents of malaria. During Plasmodium infection of erythrocytes, hemoglobin is digested into amino acids and heme (80). The amino acids are used as a nutrient, but the accumulation of heme is toxic. Plasmodium sequesters heme into a nontoxic, highly insoluble, dark brown substance called hemozoin (28). Hemozoin formation has been reported to be catalyzed by the heme detoxification protein (HDP) (47). Many bacteria utilize ferritin-like proteins to sequester free cellular iron, but heme sequestration tactics have not been well characterized for bacteria.

Some of the cytoplasmic heme-binding proteins associated with the direct heme uptake systems of Gram-negative bacteria have been proposed to function in heme sequestration and utilization. Proteins in this family include Y. enterocolitica HemS, E. coli O157:H7 ChuS, P. aeruginosa PhuS, S. dysenteriae ShuS, and Y. pestis HmuS. Since they were first described for Y. enterocolitica, we will refer to these proteins as the HemS family of proteins. Each of these cytoplasmic proteins is able to bind heme, but there is not a consensus on the function of this family of proteins. The deletion of Y. enterocolitica HemS is lethal, but hemS expression in E. coli prevents heme toxicity (112). It has been proposed that HemS degrades heme, but no biochemical data have been published to support this hypothesis. ChuS, the HemS homolog in E. coli O157:H7, however, has been shown to have heme oxygenase activity in the presence of ascorbate or an NADPH-dependent reductase (114). Whether ChuS degrades heme by an enzymatic or nonenzymatic process remains undefined. Another HemS family member, P. aeruginosa PhuS, degrades heme through a nonenzymatic process that occurs via free H2O2 oxidation of ferric PhuS (53). Rather than acting as a heme oxygenase itself, the most likely function of PhuS is to store intracellular heme and traffic heme to a distinct heme monooxygenase, PigA (53). S. dysenteriae ShuS is necessary for efficient heme utilization and protection from heme toxicity in S. dysenteriae, but data suggest that it is not likely to be a heme oxygenase (128). A potential mechanism by which ShuS could provide resistance to heme toxicity is through the DNA-binding properties of apo-ShuS (48). Y. pestis HmuS is also thought to function in heme utilization, but its mechanism remains ill defined (115). Members of the HemS family of cytoplasmic heme-binding proteins have been assigned diverse functions as heme monooxygenases, heme-trafficking proteins, heme-sequestering proteins, and DNA-binding proteins. Although the functions of these proteins may be diverse, it is clear that they are important for heme utilization and tolerance to heme toxicity.

Another heme-binding protein that contributes to resistance to heme toxicity is the Haemophilus ducreyiCu,Zn superoxide dismutase sodC (74). SodC is unique in its ability to bind a heme molecule at its dimer interface (81). The mutation of sodC results in an increased sensitivity of H. ducreyi to heme toxicity (74). Intriguingly, the mechanism for its protection against heme toxicity seems twofold, as both its antioxidant function and heme-binding function were individually able to rescue the heme sensitivity of the sodCmutant (74). Other cytoplasmic proteins such as AhpC in S. agalactiae and HutZ in V. cholerae also bind heme (54127). AhpC is a 2-Cys peroxiredoxin family protein, but its peroxidase activity does not depend on its heme-binding status (54). The mutation of either of these proteins, however, does not result in increased heme sensitivity (54127). It is thought that instead, these proteins function to store heme and promote its utilization (54127). Whereas many cytoplasmic proteins may bind heme, the specific function that such binding serves may be diverse. Identification of the exact function of heme-binding proteins has proven to be difficult, and much has yet to be learned about the regulation of heme trafficking within the bacterial cytoplasm.


Reducing heme toxicity can also be accomplished by the heme oxygenase-mediated degradation of heme. Although these proteins bind heme, they are not considered hemoproteins, as their heme-binding capacity is for the purpose of catalytically degrading heme. The HO family of heme monooxygenases was first identified for mammals, where they function primarily to protect cells from heme toxicity (116). In bacterial pathogens most heme oxygenases are implicated primarily in iron acquisition, although some have been identified to protect against heme toxicity.

In the presence of an electron donor, the canonical HO proteins degrade heme to free iron, CO, and α-biliverdin (120). HO family heme monooxygenases have been characterized for many bacterial species, a list of which can be found in Table Table1.1. The P. aeruginosa PigA (also referred to as pa-HO) is an exception in the HO family of heme monooxygenases, as it produces a mixture of all four biliverdin isomers (92). Other bacteria predicted to encode an HO family heme monooxygenase include Deinococcus radioduransAgrobacterium tumefaciens, and cyanobacteria, including Anabaena sp. PCC7120, Thermosynechococcus elongatusProchlorococcus marinus, and Nostoc punctiforme (30).

The IsdG family of heme oxygenases, first described for S. aureus, degrades heme to release free iron and form staphylobilin in the presence of a reducing agent (94). IsdG family heme oxygenases have been characterized for S. aureusB. anthracisB. japonicumMycobacterium tuberculosis, and Brucella melitensis and are predicted to be encoded in the AlphaproteobacteriaStreptomycesDeinococcus-Thermus, and Chloroflexi groups (1789101102). S. aureus encodes two IsdG family heme oxygenases (102). While functionally redundant, in that they both degrade heme to staphylobilin, they are differentially regulated by heme (93). IsdG degradation is inhibited in the presence of heme, while IsdI abundance is not affected by heme concentrations (93). In this way, S. aureus increases the rate of heme degradation as intracellular heme levels rise. This is yet another example of how bacteria refine intracellular levels of heme.

The functions of the heme oxygenase products (biliverdin and staphylobilin) in bacteria remain unclear. In cyanobacteria, algae, and plants, biliverdin is a precursor for light-harvesting phytobilin pigments (30). A reaction specific to mammals is the conversion of biliverdin to the potent antioxidant bilirubin (66110). It is possible that bacterial biliverdin and staphylobilin are excreted as waste products or further metabolized to be used as carbon and nitrogen sources. The energetically economical nature of bacteria, however, suggests that it is unlikely that biliverdin and staphylobilin are simply refuse. In the context of iron and heme homeostasis, it is possible that biliverdin and staphylobilin might function as signaling molecules or somehow provide protection from heme toxicity.

Although the role of biliverdin or staphylobilin in heme homeostasis or metabolism remains undefined, some heme oxygenases have been directly implicated in alleviating heme toxicity. The inactivation of N. gonorrhoeae hemO causes a growth defect when the mutant is grown in liquid culture in which heme is the only iron source (133). It is unclear whether this means that the N. gonorrhoeae hemO mutant is simply unable to utilize heme or if it is also more sensitive to heme toxicity. The disruption of B. anthracis isdGcauses growth inhibition across all concentrations of heme, when heme is the sole iron source (101). This suggests that IsdG is needed both for the utilization of iron from heme and for the prevention of heme toxicity. As discussed above, PhuS delivers heme to PigA in P. aeruginosa (53). Whereas the sensitivity of the phuS and pigA mutants to heme toxicity has not been tested, the PhuS homologs HemS and ShuS do provide protection against heme toxicity (112128). It is possible that the HemS family of proteins shuttle heme to a heme monooxygenase and that the controlled degradation of heme by a heme monooxygenase provides protection against heme toxicity (53). Taken together, the regulated degradation of heme by heme oxygenases is a prime example of how bacteria solve the heme paradox by reaping nutritional benefits from heme while simultaneously eliminating the associated toxicity of heme.

Alternative strategies for heme detoxification.

Besides exportation, sequestration, and degradation systems, other mechanisms of heme resistance are employed by bacteria. One example of this is the N. meningitidis gene of hydrophobic agent tolerance, ght. The mutation of ght causes increased susceptibility to heme and other hydrophobic agents (91). A broad spectrum of Gram-negative bacteria have ghthomologs, including the pathogens E. coli O157:H7, V. choleraeB. pertussisPasteurella multocidaH. influenzaeSalmonella enterica serovar Typhimurium, and Coxiella burnetii (91). The mechanism for the increased sensitivity of the ght mutant to heme and other hydrophobic agents has yet to be elucidated; nonetheless, it is separate from the Mtr efflux system and PilQ (91).


Many of the systems involved in resistance to heme toxicity are not constitutively expressed. Rather, bacteria regulate their expression in response to heme toxicity signals. In S. aureus and B. anthracis, the heme sensor system (HssRS) activates the transcription of the hrtAB ABC transporter (107119). HssRS is a two-component system (TCS) composed of HssS as a membrane-bound sensor kinase and HssR as a cytoplasmic response regulator. The mutation of hssRS results in increased heme sensitivity. L. lactisencodes a heme-regulated hrtAB ortholog, ygfBA, but no hssRS ortholog (85119). Instead, the regulator of ygfBA is thought to be the neighboring ygfC gene, but this has yet to be confirmed.

The putative heme and PPIX efflux pumps PefAB and PefCD in S. agalactiae are regulated by the MarR superfamily repressor PefR. The PefR-dependent inhibition of the two operons is alleviated when it binds heme or PPIX (27). PefR relieves its inhibition in the presence of >0.3 μM heme and plateaus at between 1 and 10 μM heme (27). S. agalactiae also encodes putative HssRS and HrtAB systems. In comparison to the regulation of the pef operons, S. agalactiae hrtAB is activated in 1 μM heme and continues to be highly activated in 10 μM heme. The activation of these two distinct efflux systems at different concentrations of heme further highlights the intricate regulatory mechanisms that bacteria employ to control intracellular concentrations of heme.

Another heme-responsive TCS distinct from HssRS is ChrAS from Corynebacterium diphtheriae (46). ChrAS activates the transcription of the heme monooxygenase hmuO and inhibits the transcription of the heme biosynthesis gene hemA (gtrA) in the presence of heme (56). The counterregulation of heme degradation and synthesis by ChrAS is subtly elegant. The disruption of hmuO does not cause heme sensitivity, but the mutation of either chrA or chrS results in growth inhibition and a loss of viability in the presence of high concentrations of heme (5). This indicates that ChrAS has other transcriptional targets and that these targets are involved in protecting C. diphtheriae from heme toxicity. The ChrAS-regulated factors that protect C. diphtheriae from heme toxicity have not yet been identified.

Like hmuO, the hemO heme monooxygenase in Clostridium perfringens is regulated to maintain a certain level of iron and heme in the cell. In the presence of heme, hemO is upregulated, but it is downregulated in the presence of iron (39). The factors responsible for the iron-dependent downregulation of hemO have not been identified. The VirSR TCS and the VirR-regulated RNA (VR-RNA) contribute to the positive regulation of hemO and other C. perfringens virulence genes; however, the stimulus of VirSR is still unknown (3965). It is likely that virulence factors are regulated in the presence of host factors, and it is possible that host heme might be such an environmental signal.


Most bacteria require iron and heme for full virulence, as measured by bacterial growth in animal models of infection. For bacteria that do not synthesize heme, heme acquisition allows them to aerobically respire or activate catalases, which protect against the oxidative burst of host phagocytes (29129). In this way, heme acquisition provides an advantage during infection. This is exemplified by the inactivation of the S. agalactiae cytochrome bd quinol oxidase cydA, which prevents acquired heme from activating aerobic respiration reducing bacterial fitness in a murine model (129). The competitive advantage provided by heme is also likely a factor for bacteria that synthesize heme, as S. aureus heme auxotrophs manifest as slow-growing small-colony variants (122). Most important, however, is the observation that many heme uptake mutants are attenuated for virulence. The inactivation of genes involved in heme acquisition in B. pertussisV. choleraeHaemophilus spp., and S. aureus all result in reduced virulence in animal models (10407186109). While heme provides a distinct advantage for bacteria during infection, the heme paradox requires that bacteria must carefully balance intracellular concentrations of this valuable nutrient source, as it can also be toxic at high concentrations.

The virulence contributions of some mechanisms that respond to and prevent heme toxicity have been assessed in animal models. The deletion of pefR in S. agalactiae results in decreased intracellular levels of heme and reduced virulence in a mouse model of infection (27). Conversely, the deletion of staphylococcal hssR results in an accumulation of heme toxicity and hypervirulence in the mouse liver (119). These data are consistent with the idea that reducing intracellular heme levels might starve pathogens, while increasing intracellular heme triggers hypervirulence. The N. gonorrhoeae MtrCDE efflux pump provides protection from heme and other hydrophobic agents (937). Clinically relevant mutations that result in the overexpression of the MtrCDE efflux pump generally result in increased resistance to hydrophobic agents and, correspondingly, increased bacterial burden in vaginal lavage fluids of infected mice (124). Those authors proposed that the direct relationship between virulence and MtrCDE expression levels is due to increased resistance to innate immune effectors. An alternative possibility is that these mutants are also more resistant to heme toxicity and that this may provide an advantage in vivo. Taken together, these results demonstrate the variable impact that disrupting heme homeostasis can have on a bacterial pathogen. Moreover, this further highlights the importance of resolving the heme paradox in pathogenesis.

Bacteria may synthesize their own heme and/or acquire it from the host environment

Heme is a required cofactor and a useful source of nutrient iron for most bacterial pathogens (Fig. (Fig.3).3). Bacteria may synthesize their own heme and/or acquire it from the host environment (Fig. (Fig.3).3). While we have discovered much about each of these processes independently, the interplay between heme biosynthesis and acquisition is an understudied area of infectious disease biology. For example, it is not known if heme is differentially segregated depending on whether it is acquired exogenously or synthesized endogenously. Moreover, the impact of heme acquisition on heme synthesis has not been evaluated. While it is known that the utility of heme as a redox cycling cofactor poses the risk of heme toxicity; how heme toxicity contributes to the outcome of host-pathogen interactions remains to be determined.

FIG. 3.

Overview of the heme paradox in bacteria. Most Gram-negative and Gram-positive bacteria are capable of acquiring or synthesizing heme. Heme can then be used for cellular processes (blue boxes). However, an accumulation of intracellular heme can cause 

Bacterial heme toxicity is multifactorial, and although it is possible that the DNA-damaging activity of heme impacts its toxicity, other factors are likely to contribute to this process (Fig. (Fig.3).3). Despite our incomplete understanding of how heme is toxic to bacteria, we have made much progress in identifying the methods that bacteria employ to solve the heme paradox. These mechanisms include export, sequestration, and degradation strategies (Fig. (Fig.3).3). These heme tolerance mechanisms are often carefully regulated by TCSs and transcription factors that respond to changes in environmental and intracellular heme. Now that many of the heme-sensing systems have been identified, future work will focus on determining how these systems sense heme as a component of vertebrate blood. An understanding of the exact mechanisms of bacterial heme toxicity not only will provide basic scientific knowledge about how heme causes toxicity but also will provide novel targets for therapeutic intervention.